Prescription drug · ANDA
Abacavir NDC 31722-562
Abacavir sulfate 20 mg/mL · Solution · Oral · Camber Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 31722-562-24 | 3172205622431722056224 | 240 mL in 1 BOTTLE (31722-562-24)Marketed from Sep 26, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Abacavir
- Generic name (nonproprietary)
- abacavir
- Active ingredients
- Abacavir sulfate — 20 mg/mL
- Dosage form
- Solution
- Route
- Oral
- Labeler
- Camber Pharmaceuticals, Inc.NDC labeler code 31722
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 201107
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A1 Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
- Identifiers
- Product ID 31722-562_58ec4085-8665-de40-e063-6294a90a3231SPL ID 58ec4085-8665-de40-e063-6294a90a3231SPL set ID e5cbf204-c10d-444b-aba0-180a30645d55RxCUI 242680UNII J220T4J9Q2UPC 0331722562249
- Pharmacologic class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N431722056224followed by a unit qualifier and the quantityPackage 31722-0562-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Abacavir oral solution, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection. Abacavir oral solution, a nucleoside analogue human immunodeficiency virus (HIV-1) reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 31722-562
- What is NDC 31722-562?
- 31722-562 is the product NDC for Abacavir, Abacavir sulfate 20 mg/mL solution, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Abacavir.
- What is the active ingredient?
- Abacavir sulfate.
- Who is the labeler?
- Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Abacavir?
- 9 other product NDCs are listed under this name. See all Abacavir NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Abacavir products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Abacavir | Abacavir sulfate 300 mg/1 | TabletOral | XLCare Pharmaceuticals Inc. | 72865-167 | 72865-0167-60 |
| Abacavir | Abacavir sulfate 300 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | 31722-557 | 31722-0557-60 |
| Abacavir | Abacavir sulfate 300 mg/1 | TabletOral | Coupler LLC | 67046-1602 | 67046-1602-03 |
| Abacavir | Abacavir sulfate 300 mg/1 | TabletOral | AvPAK | 50268-049 | 50268-0049-12 |
| Abacavirabacavir sulfate | Abacavir sulfate 20 mg/mL | SolutionOral | Rising Pharma Holdings, Inc. | 64980-405 | 64980-0405-24 |
| Abacavirabacavir sulfate | Abacavir sulfate 20 mg/mL | SolutionOral | Aurobindo Pharma Limited | 65862-089 | 65862-0089-24 |
| Abacavir | Abacavir sulfate 300 mg/1 | Tablet, Film coatedOral | Cipla USA Inc. | 69097-514 | 69097-0514-03 |
| Abacavir | Abacavir sulfate 300 mg/1 | Tablet, Film coatedOral | American Health Packaging | 68084-021 | 68084-0021-21 |
| Abacavir | Abacavir sulfate 300 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-6874 | 00904-6874-0400904-6874-06 |